616 related articles for article (PubMed ID: 29960865)
21. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
[TBL] [Abstract][Full Text] [Related]
22. Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Müller C; Assimacopoulos-Jeannet F; Mosimann F; Schneiter P; Riou JP; Pachiaudi C; Felber JP; Jéquier E; Jeanrenaud B; Tappy L
Diabetologia; 1997 Apr; 40(4):463-8. PubMed ID: 9112024
[TBL] [Abstract][Full Text] [Related]
23. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
24. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
Roseman DS; Khan T; Rajas F; Jun LS; Asrani KH; Isaacs C; Farelli JD; Subramanian RR
Mol Ther; 2018 Mar; 26(3):814-821. PubMed ID: 29428299
[TBL] [Abstract][Full Text] [Related]
25. A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency.
Huidekoper HH; Visser G; Ackermans MT; Sauerwein HP; Wijburg FA
J Inherit Metab Dis; 2010 Feb; 33(1):25-31. PubMed ID: 20127282
[TBL] [Abstract][Full Text] [Related]
26. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
Mutel E; Abdul-Wahed A; Ramamonjisoa N; Stefanutti A; Houberdon I; Cavassila S; Pilleul F; Beuf O; Gautier-Stein A; Penhoat A; Mithieux G; Rajas F
J Hepatol; 2011 Mar; 54(3):529-37. PubMed ID: 21109326
[TBL] [Abstract][Full Text] [Related]
27. The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.
Lee YM; Pan CJ; Koeberl DD; Mansfield BC; Chou JY
Mol Genet Metab; 2013 Nov; 110(3):275-80. PubMed ID: 23856420
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
[TBL] [Abstract][Full Text] [Related]
29. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice.
Qi X; Guo Y; Song Y; Yu C; Zhao L; Fang L; Kong D; Zhao J; Gao L
Diabetologia; 2018 May; 61(5):1180-1192. PubMed ID: 29442133
[TBL] [Abstract][Full Text] [Related]
30. Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats?
Azzout-Marniche D; Gaudichon C; Blouet C; Bos C; Mathé V; Huneau JF; Tomé D
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1400-7. PubMed ID: 17158265
[TBL] [Abstract][Full Text] [Related]
31. Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.
Sloop KW; Showalter AD; Cox AL; Cao JX; Siesky AM; Zhang HY; Irizarry AR; Murray SF; Booten SL; Finger EA; McKay RA; Monia BP; Bhanot S; Michael MD
J Biol Chem; 2007 Jun; 282(26):19113-21. PubMed ID: 17478431
[TBL] [Abstract][Full Text] [Related]
32. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM
J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884
[TBL] [Abstract][Full Text] [Related]
33. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.
Ramnanan CJ; Saraswathi V; Smith MS; Donahue EP; Farmer B; Farmer TD; Neal D; Williams PE; Lautz M; Mari A; Cherrington AD; Edgerton DS
J Clin Invest; 2011 Sep; 121(9):3713-23. PubMed ID: 21865644
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
35. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
Shin JS; Torres TP; Catlin RL; Donahue EP; Shiota M
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1381-90. PubMed ID: 17204595
[TBL] [Abstract][Full Text] [Related]
36. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Samuel VT; Beddow SA; Iwasaki T; Zhang XM; Chu X; Still CD; Gerhard GS; Shulman GI
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12121-6. PubMed ID: 19587243
[TBL] [Abstract][Full Text] [Related]
37. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin.
Pillot B; Soty M; Gautier-Stein A; Zitoun C; Mithieux G
Endocrinology; 2009 Feb; 150(2):616-24. PubMed ID: 18845639
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
39. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
[TBL] [Abstract][Full Text] [Related]
40. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
